Concepedia

David Osoba

DO

Statistics

Publications

119

Citations

34.3K

H-Index

62

Active since

1958

Affiliations

BC Cancer Agency(Current)

University of British Columbia

University of Toronto

Ontario Institute for Cancer Research

Princess Margaret Cancer Centre

David Osoba is an author at BC Cancer Agency specializing in oncology, medicine, and quality of life endpoints.

Publications per year

1958–2023

119

Publications

119

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

Interpreting the significance of changes in health-related quality-of-life scores.

David Osoba, George Rodrigues, James D. Myles et al. · Journal of Clinical Oncology · 1998 · 2.9K citations

Pharmacy, Oncology, Health Assessment +16

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

I. F. Tannock, David Osoba, Martin R. Stockler et al. · Journal of Clinical Oncology · 1996 · 1.6K citations

Medicine, Oncology, Pharmacotherapy +17

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James Perry, Normand Laperrière, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 939 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 119